Abcam

E422482

Abcam is a biotechnology company specializing in the production and distribution of research-grade antibodies and related reagents for life science research.

All labels observed (2)

Label Occurrences
Abcam canonical 1
Abcam Inc. 1

How this entity was disambiguated

Statements (49)

Predicate Object
instanceOf biotechnology company ⓘ
public company ⓘ
acquiredBy Danaher Corporation ⓘ
acquisitionAnnounced 2023 ⓘ
coreProduct ELISA kits ⓘ
cellular imaging reagents ⓘ
immunoassay reagents ⓘ
protein reagents ⓘ
recombinant antibodies ⓘ
research-grade antibodies ⓘ
countryOfOrigin United Kingdom ⓘ
focusArea antibody production ⓘ
antibody validation ⓘ
cell biology research ⓘ
epigenetics research ⓘ
immunology research ⓘ
neuroscience research ⓘ
proteomics research ⓘ
foundedBy David Cleevely ⓘ
Jonathan Milner ⓘ
Tony Kouzarides ⓘ
hasBusinessModel e-commerce distribution of reagents ⓘ
hasOfficeLocation Amsterdam, Netherlands ⓘ
linked to: Amsterdam

Berlin, Germany ⓘ
linked to: Berlin

Cambridge, Massachusetts, United States ⓘ
Hong Kong ⓘ
linked to: Hong Kong, China

Melbourne, Australia ⓘ
Paris, France ⓘ
linked to: Paris

Shanghai, China ⓘ
linked to: Shanghai

Singapore ⓘ
Tokyo, Japan ⓘ
linked to: Tokyo

Toronto, Canada ⓘ
linked to: Toronto
hasResearchTool Knockout-validated antibodies ⓘ
Recombinant monoclonal antibodies ⓘ
hasSubsidiary Abcam Inc. ⓘ
linked to: Abcam
headquartersLocation Cambridge, United Kingdom ⓘ
linked to: Cambridge, England
inception 1998 ⓘ
industry biotechnology ⓘ
life sciences ⓘ
research reagents ⓘ
listedOn AIM ⓘ
offersService bulk and OEM supply of reagents ⓘ
custom antibody production ⓘ
technical support for antibody use ⓘ
servesIndustry academic research ⓘ
biotechnology industry ⓘ
pharmaceutical industry ⓘ
tickerSymbol ABC ⓘ
website https://www.abcam.com ⓘ

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Abcam → hasSubsidiary → Abcam Inc. ⓘ
linked to: Abcam